These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21396721)

  • 1. A natural anti-T-cell receptor monoclonal antibody protects against experimental autoimmune encephalomyelitis.
    Fernández-Malavé E; Stark-Aroeira L
    J Neuroimmunol; 2011 May; 234(1-2):63-70. PubMed ID: 21396721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
    Matsumoto Y; Tsuchida M; Hanawa H; Abo T
    Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
    Lavasani S; Dzhambazov B; Andersson M
    Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.
    Zhou SR; Whitaker JN; Han Q; Maier C; Blalock JE
    J Immunol; 1994 Sep; 153(5):2340-51. PubMed ID: 7519648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
    Kumar V; Sercarz E
    J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.
    Zhou SR; Whitaker JN
    J Immunol; 1993 Feb; 150(4):1629-42. PubMed ID: 7679432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
    Aroeira LS
    Clin Immunol; 2006 Jun; 119(3):252-60. PubMed ID: 16503420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
    Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
    J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of Lewis rat experimental allergic encephalomyelitis with a monoclonal antibody to the T cell receptor V beta 8.2 segment.
    Imrich H; Kugler C; Torres-Nagel N; Dörries R; Hünig T
    Eur J Immunol; 1995 Jul; 25(7):1960-4. PubMed ID: 7542597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
    Willenborg DO; Staykova MA; Miyasaka M
    J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
    Kumar V; Tabibiazar R; Geysen HM; Sercarz E
    J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain.
    Hashim GA; Offner H; Wang RY; Shukla K; Carvalho E; Morrison WJ; Vandenbark AA
    J Immunol; 1992 Oct; 149(8):2803-9. PubMed ID: 1401912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between two strains of myelin basic protein (MBP) TCR transgenic mice: implications for tolerance induction.
    Song F; Wardrop RM; Gienapp IE; Stuckman SS; Goverman J; Whitacre CC
    J Autoimmun; 2002 Feb; 18(1):27-37. PubMed ID: 11869044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis.
    Offner H; Vainiene M; Celnik B; Weinberg AD; Buenafe A; Vandenbark AA
    J Immunol; 1994 Dec; 153(11):4988-96. PubMed ID: 7525721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
    Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
    J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of experimental allergic encephalomyelitis by an antibody to CD45RB.
    Schiffenbauer J; Butfiloski E; Hanley G; Sobel ES; Streit WJ; Lazarovits A
    Cell Immunol; 1998 Dec; 190(2):173-82. PubMed ID: 9878118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.